Chart Trends®: Gout Report Highlights Differences Between Primary Care ... - PR Newswire (press release)

Chart Trends®: Gout Report Highlights Differences Between Primary Care ... PR Newswire (press release) Among new therapies in development for the treatment of gout, the most robust projections for use were associated with Ardea Biosciences' RDEA-594 compound. ... and more »

FDA Orders Most Colchicine Products Off the Market - MedPage Today

MD News (press release)

FDA Orders Most Colchicine Products Off the Market MedPage Today Despite the fact that colchicine has been used for some 200 years for treatment of gout and familial Mediterranean fever, the unapproved products ordered ... FDA Warns Certain Gout-Drug Makers to Stop, And SoonWall Street Journal (blog) Hikma keeps guidance despite FDA colchicine moveReuters FDA has eye on companies that sell oral colchicineDrug Store News all 39 news articles »

Mind and Body - Joint effort! - The Hindu

The Hindu

Mind and Body - Joint effort! The Hindu ... scleroderma, juvenile rheumatoid arthritis, ankylosing spondylitis, gout, etc. Treatment has to be tailored to individual needs, lifestyle and health. ...

FOR THE FIRST TIME IN DECADES PATIENTS LIVING WITH GOUT HAVE NEW TREATMENT ... - Canada NewsWire (press release)

FOR THE FIRST TIME IN DECADES PATIENTS LIVING WITH GOUT HAVE NEW TREATMENT ... Canada NewsWire (press release) The underlying cause of gout is hyperuricemia, a condition of high levels of uric acid in the blood, and the key target in the treatment and management of ... and more »